Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
Information developed to understand the molecular mechanisms of SARS-CoV-2 infection for predicting drug repurposing candidates is time-consuming to integrate and explore. Here, the authors develop an interactive online platform for virus-host interactome exploration and drug (target) identification...
Guardado en:
Autores principales: | Sepideh Sadegh, Julian Matschinske, David B. Blumenthal, Gihanna Galindez, Tim Kacprowski, Markus List, Reza Nasirigerdeh, Mhaned Oubounyt, Andreas Pichlmair, Tim Daniel Rose, Marisol Salgado-Albarrán, Julian Späth, Alexey Stukalov, Nina K. Wenke, Kevin Yuan, Josch K. Pauling, Jan Baumbach |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97cfd30dcc8f444386de8cedd10dff72 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Network medicine for disease module identification and drug repurposing with the NeDRex platform
por: Sepideh Sadegh, et al.
Publicado: (2021) -
On the performance of de novo pathway enrichment
por: Richa Batra, et al.
Publicado: (2017) -
Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease
por: Michael G. Sugiyama, et al.
Publicado: (2021) -
Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis.
por: Rohit Vashisht, et al.
Publicado: (2012) -
A microtubule interactome: complexes with roles in cell cycle and mitosis.
por: Julian R Hughes, et al.
Publicado: (2008)